Clinical Trial Update: Hypofractionation With Simultaneous Integrated Boost for Early Breast Cancer [NA]

View source ↗

Summary

A clinical trial evaluating hypofractionation with simultaneous integrated boost for early breast cancer has completed, sponsored by Capital Medical University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Capital Medical University | Conditions: Breast Cancer, Surgery | NA | Status: COMPLETED